CD4 and gastric adenocarcinoma: SARC, HNSC, and PDAC patients with high expression of KIF11 and decreased CD4+ memory T cells had a poor prognosis, while LUSC and STAD patients with high expression of KIF11 and decreased CD4+ memory T cells had a better prognosis.